| Trial ID: | L6790 |
| Source ID: | NCT00865033
|
| Associated Drug: |
Metformin Hcl Tablets, 1000 Mg Sandoz
|
| Title: |
A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Metformin HCL Tablets, 1000 mg Sandoz|DRUG: Glucophage 1000 mg
|
| Outcome Measures: |
Primary: Bioequivalence according to US FDA guidelines, 9 days |
|
| Sponsor/Collaborators: |
Sponsor: Sandoz
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-11
|
| Completion Date: |
2005-11
|
| Results First Posted: |
|
| Last Update Posted: |
2017-03-29
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00865033
|
